MissionIR Articles

Sernova Corp. (OTC: SEOVF) is a clinical stage regenerative medicine company focused on developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated…

Provectus Biopharmaceuticals, Inc. (NYSE: PVCT) specializes in developing oncology and dermatology therapies. PV-10, the company’s novel investigational drug for cancer, is designed for injection into solid tumors, thereby reducing potential for systemic side effects. Its…

Pressure BioSciences, Inc. (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant and…

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body,…

RedHill Biopharma Ltd. (NASDAQ: RDHL) is an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer. The company is working…

OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) is headquartered in Baton Rouge, Louisiana, and is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to…

Viking Therapeutics, Inc. (NASDAQ: VKTX) is a clinical stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company has a portfolio that includes five therapeutic programs either in clinical…

Relmada Therapeutics, Inc. (OTC: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in…

DanDrit Biotech USA, Inc. (OTC: DDRT) was founded in 2001 and is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit was founded based on the research of…

Heat Biologics (NASDAQ: HTBX) is developing novel therapies that activate a patient’s immune system against cancer. The company’s T cell-stimulating platform technologies, ImPACT and ComPACT, form the basis of its product candidates. In combination with…

Cesca Therapeutics, Inc. (NASDAQ: KOOL) is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The company is focused on developing and manufacturing automated blood and bone marrow…

Guided Therapeutics, Inc. (OTC: GTHP) has developed a biophotonic technology for the early detection of disease that leads to cancer. The technology uses light to detect disease at the cellular level and provide immediate results…

Can-Fite BioPharma Ltd. (NYSE: CANF) is an Israeli biopharmaceutical company with pharmaceutical discovery and clinical development stage capabilities, developing treatments for cancer, inflammatory disease, and sexual dysfunction. The company’s CF101 drug candidate is currently under…

Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer. Celator’s proprietary technology platform, CombiPlex, enables the rational…

Intec Pharma Ltd. (NASDAQ: NTEC) is developing drugs based on its proprietary Accordion Pill platform technology. Accordion Pill is an oral drug delivery system designed to improve the efficacy and safety of existing drugs and…

Amedica Corp. (NASDAQ: AMDA) develops Silicon Nitride orthopedic and spinal implants. It is the only company that has FDA approval to produce and distribute medical grade Silicon Nitride. Amedica’s line of Silicone Nitride Interbody Fusion…

Axsome Therapeutics, Inc. (Nasdaq: AXSM) is a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders. By focusing on this therapeutic area, the company…

Resverlogix Corp. (OTC: RVXCF) is an epigenetics company, creating small molecule therapeutics for BET inhibition. The company is currently developing apabetalone (RVX-208), a first-in-class, small molecule selective BET bromodomain inhibitor. It is the only selective…

Bionomics Ltd. (OTC: BNOEF) is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system disorders such as depression, anxiety and Alzheimer’s.…

CorMedix, Inc. (NYSE: CRMD) is a commercial-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. The company’s first commercial product in…